Dr Olga Oikonomidou (BSc, MSc, MRes, MD, PhD, FRCP)
Consultant Medical Oncologist - Senior Clinical Lecturer in Breast Cancer Medicine - Breast Cancer Translational Research Group Leader

- Cancer Research UK Edinburgh Centre
- Institute of Genetics & Cancer
- Western General Hospital - NHS Lothian
Contact details
- Email: Olga.Oikonomidou@ed.ac.uk
Address
- Street
-
Cancer Research UK Edinburgh Centre
Institute of Genetics & Cancer
The University of Edinburgh
Western General Hospital
Crewe Road South - City
- Edinburgh
- Post code
- EH4 2XR
Background
Dr Olga Oikonomidou is an Academic Consultant Medical Oncologist specializing in breast cancer and the Breast Cancer Translational Research Group Lead at the Institute of Genetics and Cancer at the University of Edinburgh. Other than a degree in Medicine, she holds a BSc in Human Genetics, MSc in Oncology, MRes in Immunology and a PhD in translational medicine. After completing her training in medical oncology at King’s College Hospital and Guy’s Hospital in London, she moved to Edinburgh where she worked as a Senior Clinical Research Fellow in Breast Cancer for 2 years before getting a substantive post as an Academic Consultant Medical Oncologist and setting up her own research group in breast cancer translational research. Her responsibilities are split between running a busy breast oncology practice at the Edinburgh Cancer Centre and leading on breast cancer clinical trials and translational studies. Dr Oikonomidou is a clinical expert for NICE and SMC and participated in multiple technology appraisals since 2015. She has received a number of prestigious grants for her clinical research projects. She is on the TMG of numerous national and international trials. She is currently the global Chief Investigator of 3 international multicentre trials, UK Chief Investigator of 4 clinical trials and the PI for more than 60 trials. Her academic research interest is focused on prediction of biomarkers of response to treatment and clinical trials in breast cancer in all phases.